InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,454.21
(
1.02%
)
US TECH 100
18,396.00
(
0.36%
)
Dow Jones
40,587.53
(
1.63%
)
Brent Oil
79.75
(
-2.19%
)
Bitcoin
67,398.02
(
2.45%
)
Post# of 252690
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120125
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 129084

Wednesday, 08/01/2012 4:41:26 PM

Wednesday, August 01, 2012 4:41:26 PM

Post# of 252690
NIH study elucidates the MoA of Daclizumab in MS:

http://www.nih.gov/news/health/aug2012/ninds-01.htm

Daclizumab is being jointly developed by ABT and BIIB. It is in phase-3 for MS with an expected completion date of Mar 2014 (http://www.clinicaltrials.gov/ct2/show/NCT01064401 ).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up